Top

Published in:

01-03-2016 | Neurological Update

Functional neurological disorders: mechanisms and treatment

Authors: Alexander Lehn, Jeannette Gelauff, Ingrid Hoeritzauer, Lea Ludwig, Laura McWhirter, Stevie Williams, Paula Gardiner, Alan Carson, Jon Stone

Published in: Journal of Neurology | Issue 3/2016

Abstract

Functional neurological disorders are common problems in neurologic practice. In the past decade there has been an increasing interest in this group of disorders both from a clinical as well as research point of view. In this review, we highlight some of the most salient and exciting publications from recent years focusing especially on new findings illuminating mechanism and studies examining treatment.

Stone J, Carson A, Duncan R et al (2009) Symptoms “unexplained by organic disease” in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain 132:2878–2888. doi:10.1093/brain/awp220 CrossRefPubMed

Katon WJ, Walker EA (1998) Medically unexplained symptoms in primary care. J Clin Psychiatry 59(Suppl 20):15–21PubMed

Carson A, Stone J, Hibberd C et al (2011) Disability, distress and unemployment in neurology outpatients with symptoms ‘unexplained by organic disease’. J Neurol Neurosurg Psychiatry 82:810–813. doi:10.1136/jnnp.2010.220640 CrossRefPubMed

Dirkzwager AJE, Verhaak PFM (2007) Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care. BMC Fam Pract 8:33. doi:10.1186/1471-2296-8-33 CrossRefPubMedPubMedCentral

Steinbrecher N, Hiller W (2011) Course and prediction of somatoform disorder and medically unexplained symptoms in primary care. Gen Hosp Psychiatry 33:318–326. doi:10.1016/j.genhosppsych.2011.05.002 CrossRefPubMed

Gelauff J, Stone J, Edwards M, Carson A (2014) The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry 85:220–226. doi:10.1136/jnnp-2013-305321 CrossRefPubMed

Durrant J, Rickards H, Cavanna AE (2011) Prognosis and outcome predictors in psychogenic nonepileptic seizures. Epilepsy Res Treat 2011:274736. doi:10.1155/2011/274736 PubMedPubMedCentral

Stone J, LaFrance WC, Brown R et al (2011) Conversion disorder: current problems and potential solutions for DSM-5. J Psychosom Res 71:369–376. doi:10.1016/j.jpsychores.2011.07.005 CrossRefPubMed

Stone J, Hallett M, Carson A et al (2014) Functional disorders in the neurology section of ICD-11 A landmark opportunity. Neurology 83:2299–2301. doi:10.1212/WNL.0000000000001063 CrossRefPubMedPubMedCentral

10.

Nielsen G, Stone J, Matthews A et al (2014) Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-309255 PubMedCentral

11.

LaFrance WC, Reuber M, Goldstein LH (2013) Management of psychogenic nonepileptic seizures. Epilepsia 54(Suppl 1):53–67. doi:10.1111/epi.12106 CrossRefPubMed

12.

Espay AJ, Lang AE (2015) Phenotype-specific diagnosis of functional (psychogenic) movement disorders. Curr Neurol Neurosci Rep 15:1–9. doi:10.1007/s11910-015-0556-y CrossRef

13.

LaFrance WC, Baker GA, Duncan R et al (2013) Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach. Epilepsia 54:2005–2018. doi:10.1111/epi.12356 CrossRefPubMed

14.

McWhirter L, Stone J, Sandercock P, Whiteley W (2011) Hoover’s sign for the diagnosis of functional weakness: a prospective unblinded cohort study in patients with suspected stroke. J Psychosom Res 71:384–386. doi:10.1016/j.jpsychores.2011.09.003 CrossRefPubMed

15.

Daum C, Hubschmid M, Aybek S (2014) The value of “positive” clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review. J Neurol Neurosurg Psychiatry 85:180–190. doi:10.1136/jnnp-2012-304607 CrossRefPubMed

16.

Schwingenschuh P, Katschnig P, Seiler S et al (2011) Moving toward “laboratory-supported” criteria for psychogenic tremor. Mov Disord 26:2509–2515. doi:10.1002/mds.23922 CrossRefPubMedPubMedCentral

17.

Daum C, Gheorghita F, Spatola M et al (2014) Interobserver agreement and validity of bedside “positive signs” for functional weakness, sensory and gait disorders in conversion disorder: a pilot study. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2013-307381

18.

Pareés I, Brown H, Nuruki A et al (2014) Loss of sensory attenuation in patients with functional (psychogenic) movement disorders. Brain 137:2916–2921. doi:10.1093/brain/awu237 CrossRefPubMed

19.

Ramos VFML, Hallett M (2014) Head accelerometry may be useful as a test of psychogenic head tremor. Mov Disord Clin Pract 1:395–396. doi:10.1002/mdc3.12092 CrossRefPubMedPubMedCentral

20.

Macerollo A, Batla A, Kassavetis P et al (2014) Using reaction time and co-contraction to differentiate acquired (secondary) from functional “fixed” dystonia. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-309040 PubMedCentral

21.

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5), 5th edn. American Psychiatric Association, Washington, DC

22.

Kanaan RA, Carson A, Wessely SC et al (2010) What’s so special about conversion disorder? A problem and a proposal for diagnostic classification. Br J Psychiatry 196:427–428. doi:10.1192/bjp.bp.109.073981 CrossRefPubMed

23.

Erro R, Bhatia KP, Edwards MJ et al (2013) Clinical diagnosis of propriospinal myoclonus is unreliable: an electrophysiologic study. Mov Disord 28:1868–1873. doi:10.1002/mds.25627 CrossRefPubMed

24.

van der Salm SMA, Erro R, Cordivari C et al (2014) Propriospinal myoclonus: clinical reappraisal and review of literature. Neurology 83:1862–1870. doi:10.1212/WNL.0000000000000982 CrossRefPubMedPubMedCentral

25.

Edwards MJ, Bhatia KP (2012) Functional (psychogenic) movement disorders: merging mind and brain. Lancet Neurol 11:250–260. doi:10.1016/S1474-4422(11)70310-6 CrossRefPubMed

26.

Fasano A, Valadas A, Bhatia KP et al (2012) Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord 27:1544–1551. doi:10.1002/mds.25190 CrossRefPubMedPubMedCentral

27.

Gazulla J, García-Rubio S, Ruiz-Gazulla C, Modrego P (2015) Clinical categorization of psychogenic blepharospasm. Parkinsonism Relat Disord 21:325–326. doi:10.1016/j.parkreldis.2014.12.005 CrossRefPubMed

28.

Schwingenschuh P, Katschnig P, Edwards MJ et al (2011) The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. Neurology 76:610–614. doi:10.1212/WNL.0b013e31820c3074 CrossRefPubMedPubMedCentral

29.

Demartini B, Ricciardi L, Parees I et al (2015) A positive diagnosis of functional (psychogenic) tics. Eur J Neurol 22:527–527e36. doi:10.1111/ene.12609 CrossRefPubMed

30.

Baizabal-Carvallo JF, Jankovic J (2014) The clinical features of psychogenic movement disorders resembling tics. J Neurol Neurosurg Psychiatry 85:573–575. doi:10.1136/jnnp-2013-305594 CrossRefPubMed

31.

Rooney A, Statham PF, Stone J (2009) Cauda equina syndrome with normal MR imaging. J Neurol 256:721–725. doi:10.1007/s00415-009-5003-z CrossRefPubMed

32.

Hoeritzauer I, Doherty CM, Thomson S et al (2015) “Scan-negative” cauda equina syndrome: evidence of functional disorder from a prospective case series. Br J Neurosurg. doi:10.3109/02688697.2014.1003032 PubMed

33.

Hoeritzauer I, Stone J, Fowler C et al (2015) Fowler’s syndrome of urinary retention: a retrospective study of co-morbidity. Neurourol Urodyn. doi:10.1002/nau.22758 PubMed

34.

Stamelou M, Saifee TA, Edwards MJ, Bhatia KP (2012) Psychogenic palatal tremor may be underrecognized: reappraisal of a large series of cases. Mov Disord 27:1164–1168. doi:10.1002/mds.24948 CrossRefPubMedPubMedCentral

35.

Avbersek A, Sisodiya S (2010) Does the primary literature provide support for clinical signs used to distinguish psychogenic nonepileptic seizures from epileptic seizures? J Neurol Neurosurg Psychiatry 81:719–725. doi:10.1136/jnnp.2009.197996 CrossRefPubMed

36.

Wadwekar V, Nair PP, Murgai A et al (2014) Semiologic classification of psychogenic non epileptic seizures (PNES) based on video EEG analysis: do we need new classification systems? Seizure 23:222–226. doi:10.1016/j.seizure.2013.12.005 CrossRefPubMed

37.

Stone J, Carson AJ (2013) The unbearable lightheadedness of seizing: wilful submission to dissociative (non-epileptic) seizures. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2012-304842

38.

Reuber M, Jamnadas-Khoda J, Broadhurst M et al (2011) Psychogenic nonepileptic seizure manifestations reported by patients and witnesses. Epilepsia 52:2028–2035. doi:10.1111/j.1528-1167.2011.03162.x CrossRefPubMed

39.

Reuber M, Fernández G, Bauer J et al (2002) Interictal EEG abnormalities in patients with psychogenic nonepileptic seizures. Epilepsia 43:1013–1020CrossRefPubMed

40.

Barzegaran E, Joudaki A, Jalili M et al (2012) Properties of functional brain networks correlate with frequency of psychogenic non-epileptic seizures. Front Hum Neurosci 6:335. doi:10.3389/fnhum.2012.00335 CrossRefPubMedPubMedCentral

41.

Hubsch C, Baumann C, Hingray C et al (2011) Clinical classification of psychogenic non-epileptic seizures based on video-EEG analysis and automatic clustering. J Neurol Neurosurg Psychiatry 82:955–960. doi:10.1136/jnnp.2010.235424 CrossRefPubMed

42.

Bodde NMG, van der Kruijs SJM, Ijff DM et al (2013) Subgroup classification in patients with psychogenic non-epileptic seizures. Epilepsy Behav 26:279–289. doi:10.1016/j.yebeh.2012.10.012 CrossRefPubMed

43.

Hendrickson R, Popescu A, Dixit R et al (2014) Panic attack symptoms differentiate patients with epilepsy from those with psychogenic nonepileptic spells (PNES). Epilepsy Behav 37:210–214. doi:10.1016/j.yebeh.2014.06.026 CrossRefPubMed

44.

Schwabe M, Howell SJ, Reuber M (2007) Differential diagnosis of seizure disorders: a conversation analytic approach. Soc Sci Med 65:712–724. doi:10.1016/j.socscimed.2007.03.045 CrossRefPubMed

45.

Edwards MJ, Adams RA, Brown H et al (2012) A Bayesian account of “hysteria”. Brain 135:3495–3512. doi:10.1093/brain/aws129 CrossRefPubMedPubMedCentral

46.

van der Salm SMA, Tijssen MAJ, Koelman JHTM, van Rootselaar A-F (2012) The bereitschaftspotential in jerky movement disorders. J Neurol Neurosurg Psychiatry 83:1162–1167. doi:10.1136/jnnp-2012-303081 CrossRefPubMed

47.

Kranick SM, Moore JW, Yusuf N et al (2013) Action-effect binding is decreased in motor conversion disorder: implications for sense of agency. Mov Disord 28:1110–1116. doi:10.1002/mds.25408 CrossRefPubMedPubMedCentral

48.

Edwards MJ, Moretto G, Schwingenschuh P et al (2011) Abnormal sense of intention preceding voluntary movement in patients with psychogenic tremor. Neuropsychologia 49:2791–2793. doi:10.1016/j.neuropsychologia.2011.05.021 CrossRefPubMed

49.

Pareés I, Kassavetis P, Saifee TA et al (2013) Failure of explicit movement control in patients with functional motor symptoms. Mov Disord 28:517–523. doi:10.1002/mds.25287 CrossRefPubMed

50.

Parees I, Saifee TA, Kassavetis P et al (2012) Believing is perceiving: mismatch between self-report and actigraphy in psychogenic tremor. Brain 135:117–123. doi:10.1093/brain/awr292 CrossRefPubMed

51.

Mehta AR, Rowe JB, Schrag AE (2013) Imaging psychogenic movement disorders. Curr Neurol Neurosci Rep 13:402. doi:10.1007/s11910-013-0402-z CrossRefPubMedPubMedCentral

52.

Schrag AE, Mehta AR, Bhatia KP et al (2013) The functional neuroimaging correlates of psychogenic versus organic dystonia. Brain 136:770–781. doi:10.1093/brain/awt008 CrossRefPubMedPubMedCentral

53.

Aybek S, Nicholson TR, Zelaya F et al (2014) Neural correlates of recall of life events in conversion disorder. JAMA Psychiatry 71:52–60. doi:10.1001/jamapsychiatry.2013.2842 CrossRefPubMed

54.

Voon V, Brezing C, Gallea C et al (2010) Emotional stimuli and motor conversion disorder. Brain 133:1526–1536. doi:10.1093/brain/awq054 CrossRefPubMedPubMedCentral

55.

Aybek S, Nicholson TR, O’Daly O et al (2015) Emotion-motion interactions in conversion disorder: an FMRI study. PLoS One 10:e0123273. doi:10.1371/journal.pone.0123273 CrossRefPubMedPubMedCentral

56.

Voon V, Brezing C, Gallea C, Hallett M (2011) Aberrant supplementary motor complex and limbic activity during motor preparation in motor conversion disorder. Mov Disord 26:2396–2403. doi:10.1002/mds.23890 CrossRefPubMedPubMedCentral

57.

Czarnecki K, Jones DT, Burnett MS et al (2011) SPECT perfusion patterns distinguish psychogenic from essential tremor. Parkinsonism Relat Disord 17:328–332. doi:10.1016/j.parkreldis.2011.01.012 CrossRefPubMed

58.

van Beilen M, de Jong BM, Gieteling EW et al (2011) Abnormal parietal function in conversion paresis. PLoS One 6:e25918. doi:10.1371/journal.pone.0025918 CrossRefPubMedPubMedCentral

59.

Voon V, Gallea C, Hattori N et al (2010) The involuntary nature of conversion disorder. Neurology 74:223–228. doi:10.1212/WNL.0b013e3181ca00e9 CrossRefPubMedPubMedCentral

60.

van der Kruijs SJM, Jagannathan SR, Bodde NMG et al (2014) Resting-state networks and dissociation in psychogenic non-epileptic seizures. J Psychiatr Res 54:126–133. doi:10.1016/j.jpsychires.2014.03.010 CrossRefPubMed

61.

Ding J-R, An D, Liao W et al (2013) Altered functional and structural connectivity networks in psychogenic non-epileptic seizures. PLoS One 8:e63850. doi:10.1371/journal.pone.0063850 CrossRefPubMedPubMedCentral

62.

Arthuis M, Micoulaud-Franchi JA, Bartolomei F et al (2014) Resting cortical PET metabolic changes in psychogenic non-epileptic seizures (PNES). J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-309390 PubMed

63.

Nielsen G, Stone J, Edwards MJ (2013) Physiotherapy for functional (psychogenic) motor symptoms: a systematic review. J Psychosom Res 75:93–102. doi:10.1016/j.jpsychores.2013.05.006 CrossRefPubMed

64.

McCormack R, Moriarty J, Mellers JD et al (2014) Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study. J Neurol Neurosurg Psychiatry 85:895–900. doi:10.1136/jnnp-2013-305716 CrossRefPubMed

65.

Jordbru AA, Smedstad LM, Klungsøyr O, Martinsen EW (2014) Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with 1-year follow-up. J Rehabil Med 46:181–187. doi:10.2340/16501977-1246 CrossRefPubMed

66.

Nielsen G, Ricciardi L, Demartini B et al (2015) Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorders. J Neurol 262:674–681. doi:10.1007/s00415-014-7631-1 CrossRefPubMed

67.

Saifee TA, Kassavetis P, Parees I et al (2012) Inpatient treatment of functional motor symptoms: a long-term follow-up study. J Neurol 259:1958–1963. doi:10.1007/s00415-012-6530-6 CrossRefPubMed

68.

Demartini B, Batla A, Petrochilos P et al (2014) Multidisciplinary treatment for functional neurological symptoms: a prospective study. J Neurol 261:2370–2377. doi:10.1007/s00415-014-7495-4 CrossRefPubMedPubMedCentral

69.

Goldstein LH, Chalder T, Chigwedere C et al (2010) Cognitive-behavioral therapy for psychogenic nonepileptic seizures A pilot RCT. Neurology 74:1986–1994. doi:10.1212/WNL.0b013e3181e39658 CrossRefPubMedPubMedCentral

70.

LaFrance WC, Baird GL, Barry JJ et al (2014) Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 71:997–1005. doi:10.1001/jamapsychiatry.2014.817 CrossRefPubMed

71.

Gelauff JM, Dreissen YEM, Tijssen MAJ, Stone J (2014) Treatment of functional motor disorders. Curr Treat Options Neurol 16:286–315. doi:10.1007/s11940-014-0286-5 CrossRefPubMed

72.

Kompoliti K, Wilson B, Stebbins G et al (2014) Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord 20:60–63. doi:10.1016/j.parkreldis.2013.09.018 CrossRefPubMed

73.

Hubschmid M, Aybek S, Maccaferri GE et al (2015) Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. Gen Hosp Psychiatry. doi:10.1016/j.genhosppsych.2015.05.007 PubMed

74.

Sharpe M, Walker J, Williams C et al (2011) Guided self-help for functional (psychogenic) symptoms A randomized controlled efficacy trial. Neurology 77:564–572. doi:10.1212/WNL.0b013e318228c0c7 CrossRefPubMedPubMedCentral

75.

Stone J, Carson A, Duncan R et al (2010) Who is referred to neurology clinics? The diagnoses made in 3781 new patients. Clin Neurol Neurosurg 112:747–751. doi:10.1016/j.clineuro.2010.05.011 CrossRefPubMed

76.

White PD, Goldsmith KA, Johnson AL et al (2011) Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 377:823–836. doi:10.1016/S0140-6736(11)60096-2 CrossRefPubMedPubMedCentral

77.

Chalder T, Goldsmith KA, White PD et al (2015) Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial. Lancet Psychiatry 2:141–152. doi:10.1016/S2215-0366(14)00069-8 CrossRefPubMed

78.

Ferrara J, Stamey W, Strutt AM et al (2014) Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders. J Neuropsychiatry Clin Neurosci 23:141–148. doi:10.1176/jnp.23.2.jnp141 CrossRef

79.

Jellinek DA, Bradford R, Bailey I, Symon L (1992) The role of motor evoked potentials in the management of hysterical paraplegia: case report. Paraplegia 30:300–302. doi:10.1038/sc.1992.73 CrossRefPubMed

80.

Pollak TA, Nicholson TR, Edwards MJ, David AS (2014) A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. J Neurol Neurosurg Psychiatry 85:191–197. doi:10.1136/jnnp-2012-304181 CrossRefPubMed

81.

Chastan N, Parain D (2010) Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord 25:1501–1504. doi:10.1002/mds.23187 CrossRefPubMed

82.

Garcin B, Roze E, Mesrati F et al (2013) Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry 84:1043–1046. doi:10.1136/jnnp-2012-304062 CrossRefPubMed

83.

Broersma M, Koops EA, Vroomen PC et al (2015) Can repetitive transcranial magnetic stimulation increase muscle strength in functional neurological paresis? A proof-of-principle study. Eur J Neurol 22:866–873. doi:10.1111/ene.12684 CrossRefPubMed

84.

Espay AJ, Edwards MJ, Oggioni GD et al (2014) Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor. Parkinsonism Relat Disord 20:647–650. doi:10.1016/j.parkreldis.2014.02.029 CrossRefPubMedPubMedCentral

85.

Stone J, Edwards M (2012) Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology 79:282–284. doi:10.1212/WNL.0b013e31825fdf63 CrossRefPubMed

86.

Stone J, Hoeritzauer I, Brown K, Carson A (2014) Therapeutic sedation for functional (psychogenic) neurological symptoms. J Psychosom Res 76:165–168. doi:10.1016/j.jpsychores.2013.10.003 CrossRefPubMed

87.

Stone J (2014) Functional neurological disorders: the neurological assessment as treatment. Neurophysiol Clin 44:363–373. doi:10.1016/j.neucli.2014.01.002 CrossRefPubMed

Title: Functional neurological disorders: mechanisms and treatment
Authors: Alexander Lehn
Jeannette Gelauff
Ingrid Hoeritzauer
Lea Ludwig
Laura McWhirter
Stevie Williams
Paula Gardiner
Alan Carson
Jon Stone
Publication date: 01-03-2016
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 3/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-015-7893-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Functional neurological disorders: mechanisms and treatment

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Advances in biomarker research in multiple sclerosis

Early-onset progressive spastic paraplegia caused by a novel TUBB4A mutation: brain MRI and FDG-PET findings

Radiotherapy treatment of the salivary glands, sialorrhea, and non-invasive mechanical ventilation in amyotrophic lateral sclerosis: what are we doing?

Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings

MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt–Jakob disease

Strategies to target drugs to gliomas and CNS metastases of solid tumors